• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强心肌再生的新策略:临床前证据的期望和挑战。

New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence.

机构信息

Vascular Biology and Regenerative Medicine Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy

Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Milan, Italy

出版信息

Curr Stem Cell Res Ther. 2020;15(8):696-710. doi: 10.2174/1574888X15666200225124451.

DOI:10.2174/1574888X15666200225124451
PMID:32096748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8493790/
Abstract

Nowadays, cardiac regeneration is an emerging topic in the cardiovascular field because of the compelling need for effective therapies for repairing or replacing cardiac tissue damaged by pathological or physiological conditions. Indeed, irreversible myocardial remodeling which follows acute myocardial infarction represents a serious burden of this century. In this context, a great improvement in pharmacological and interventional techniques is accompanied by a big challenge of cardiac regenerative medicine. In the last 20 years, several clinical trials tried to investigate the role of different types of stem cells in promoting cardiac repair. However, the promising results obtained in the preclinical trials have not yet been reproduced in patients. Thus, the development of novel strategies to improve stem cell efficiency became imperative. Here, an overview of the more recent cell types proposed for cardiac regeneration is presented, together with the most interesting approaches to enhance cell regenerative potential as well as cell-free approaches.

摘要

如今,心脏再生是心血管领域的一个新兴课题,因为迫切需要有效的治疗方法来修复或替代因病理或生理条件而受损的心脏组织。事实上,急性心肌梗死后不可逆的心肌重构是本世纪的一个严重负担。在这种情况下,药理学和介入技术的巨大进步伴随着心脏再生医学的巨大挑战。在过去的 20 年里,有几项临床试验试图研究不同类型的干细胞在促进心脏修复中的作用。然而,在临床前试验中获得的有希望的结果尚未在患者中得到重现。因此,开发提高干细胞效率的新策略变得势在必行。在这里,我们对最近提出的用于心脏再生的细胞类型进行了综述,同时还介绍了增强细胞再生潜能的最有趣的方法以及无细胞方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0576/8493790/be1165914448/CSCRT-15-696_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0576/8493790/be1165914448/CSCRT-15-696_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0576/8493790/be1165914448/CSCRT-15-696_F1.jpg

相似文献

1
New Strategies to Enhance Myocardial Regeneration: Expectations and Challenges from Preclinical Evidence.增强心肌再生的新策略:临床前证据的期望和挑战。
Curr Stem Cell Res Ther. 2020;15(8):696-710. doi: 10.2174/1574888X15666200225124451.
2
Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration.人类心脏驻留干细胞:在心脏细胞内环境稳定中的作用及心肌再生潜力
Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S8-13. doi: 10.1038/ncpcardio0409.
3
Overview of hydrogel-based strategies for application in cardiac tissue regeneration.用于心脏组织再生的水凝胶基策略概述。
Biomed Mater. 2015 Jun 4;10(3):034005. doi: 10.1088/1748-6041/10/3/034005.
4
Cardiac stem cell therapy for myocardial regeneration. A clinical perspective.用于心肌再生的心脏干细胞疗法。临床视角。
Minerva Cardioangiol. 2005 Dec;53(6):549-64.
5
[Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].[用于心肌再生的干细胞疗法:机制与当前临床应用]
G Ital Cardiol (Rome). 2008 Apr;9(4):234-50.
6
Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.心肌梗死后影响功能修复的组织工程心脏构建策略。
J Cardiovasc Transl Res. 2011 Oct;4(5):575-91. doi: 10.1007/s12265-011-9303-1. Epub 2011 Aug 5.
7
The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.天然化合物在心脏干细胞激活中的潜在特性:在心肌再生中的作用。
Nutrients. 2021 Jan 19;13(1):275. doi: 10.3390/nu13010275.
8
Regeneration of myocardium--dawn of a new era!心肌再生——新时代的曙光!
J Assoc Physicians India. 2009 Apr;57:312-24, 329-31.
9
Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.心脏再生治疗心力衰竭的进展与挑战。
J Cardiol. 2019 Feb;73(2):97-101. doi: 10.1016/j.jjcc.2018.10.002. Epub 2018 Nov 9.
10
microRNA and Cardiac Regeneration.微小RNA与心脏再生
Adv Exp Med Biol. 2015;887:119-41. doi: 10.1007/978-3-319-22380-3_7.

引用本文的文献

1
Unlocking the Mysteries, Bridging the Gap, and Unveiling the Multifaceted Potential of Stem Cell Therapy for Cardiac Tissue Regeneration: A Narrative Review of Current Literature, Ethical Challenges, and Future Perspectives.揭开干细胞治疗心脏组织再生的奥秘、弥合差距并揭示其多方面潜力:当前文献、伦理挑战及未来展望的叙述性综述
Cureus. 2023 Jul 7;15(7):e41533. doi: 10.7759/cureus.41533. eCollection 2023 Jul.
2
The Metabolic Pathway of Cardiac Troponins Release: Mechanisms and Diagnostic Role.心肌肌钙蛋白释放的代谢途径:机制与诊断作用。
Cardiol Res. 2022 Aug;13(4):190-205. doi: 10.14740/cr1351. Epub 2022 Aug 15.
3

本文引用的文献

1
Platelet-Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury.受血小板启发的纳米细胞用于缺血/再灌注损伤后的靶向心脏修复
Adv Funct Mater. 2019 Jan 24;29(4). doi: 10.1002/adfm.201803567. Epub 2018 Nov 13.
2
Heat Shock Proteins and their Protective Roles in Stem Cell Biology.热休克蛋白及其在干细胞生物学中的保护作用。
Stem Cell Rev Rep. 2019 Oct;15(5):637-651. doi: 10.1007/s12015-019-09903-5.
3
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Features of the Metabolisms of Cardiac Troponin Molecules-Part 1: The Main Stages of Metabolism, Release Stage.
心肌肌钙蛋白分子的代谢特征——第1部分:代谢的主要阶段,释放阶段
Curr Issues Mol Biol. 2022 Mar 20;44(3):1376-1394. doi: 10.3390/cimb44030092.
4
Differences in Mitochondrial Membrane Potential Identify Distinct Populations of Human Cardiac Mesenchymal Progenitor Cells.线粒体膜电位差异可识别人心肌间充质祖细胞的不同群体。
Int J Mol Sci. 2020 Oct 10;21(20):7467. doi: 10.3390/ijms21207467.
通过使用人羊膜间充质干细胞 secretome 的旁分泌增强作用来激活心脏再生的内源性机制。
Int J Cardiol. 2019 Jul 15;287:87-95. doi: 10.1016/j.ijcard.2019.04.011. Epub 2019 Apr 4.
4
Regenerative Cardiovascular Therapies: Stem Cells and Beyond.再生心血管治疗学:干细胞及其他
Int J Mol Sci. 2019 Mar 21;20(6):1420. doi: 10.3390/ijms20061420.
5
Stem cell therapy: A novel approach for myocardial infarction.干细胞治疗:心肌梗死的新方法。
J Cell Physiol. 2019 Aug;234(10):16904-16912. doi: 10.1002/jcp.28381. Epub 2019 Feb 27.
6
Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.月经血来源的子宫内膜干细胞在心脏疾病中的治疗潜力。
Cell Mol Life Sci. 2019 May;76(9):1681-1695. doi: 10.1007/s00018-019-03019-2. Epub 2019 Feb 5.
7
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
8
A New Era of Cardiac Cell Therapy: Opportunities and Challenges.心脏细胞治疗的新纪元:机遇与挑战。
Adv Healthc Mater. 2019 Jan;8(2):e1801011. doi: 10.1002/adhm.201801011. Epub 2018 Dec 13.
9
Exosomes: Basic Biology and Technological Advancements Suggesting Their Potential as Ischemic Heart Disease Therapeutics.外泌体:基础生物学与技术进展表明其作为缺血性心脏病治疗手段的潜力
Front Physiol. 2018 Nov 19;9:1159. doi: 10.3389/fphys.2018.01159. eCollection 2018.
10
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.壳聚糖/丝素蛋白改性纳米纤维贴片联合间充质干细胞预防大鼠心肌梗死后心脏重构。
Acta Biomater. 2018 Oct 15;80:154-168. doi: 10.1016/j.actbio.2018.09.013. Epub 2018 Sep 13.